In the present meta-analysis, we found that the MDM2 SNP309 polymorphism was significantly associated with increased HCC risk in HCV positive patients but not in HBV positive subgroup, which is consistent with the study conducted by Dharel et al. [31]. The gene discussed is MDM2; the disease is hepatocellular carcinoma.